PARIS, Ontario, July 05, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT)
(“Emblem” or the "Company") is pleased to announce that its wholly owned subsidiary, Emblem Cannabis Corporation, one of Canada’s
leading licensed producers, has completed an agreement with the Alberta Gaming, Liquor & Cannabis Commission (“AGLC”) to supply the
province with high quality cannabis products. Products will be available under Emblem’s new adult-use focused brand, which is
expected to be announced shortly.
“Emblem is excited to have been selected to bring our adult-use products to Alberta’s recreational cannabis
market upon legalization on October 17, 2018. We are looking forward to working together with the AGLC to build the foundation for
a safe and responsible marketplace for consumers,” said Maria Guest, Chief Marketing Officer with Emblem. “With our soon to be
announced adult-use cannabis brand, Emblem is ready to meet the needs of Albertans seeking a trusted source of cannabis products,
offering a curated range of dried flower and cannabis oils.”
“This agreement with the AGLC, our first provincial supply agreement to service the adult-use
market, is an exciting milestone for Emblem. It supports our multi-provincial roll-out plan and recent
strategic investment in Fire & Flower, which is expected to have a strong presence in the Alberta market,” said Nick Dean,
President and CEO of Emblem.
For more information, contact:
Ethan Karayannopoulos
Investor Relations
Emblem Corp.
647.748.9696
ethank@emblemcorp.com
Alex Stojanovic
Chief Financial Officer
Emblem Corp.
416.923.1331
alexs@emblemcorp.com
About Emblem
Emblem, through its wholly-owned subsidiary Emblem Cannabis Corporation, is a fully integrated licensed producer and distributor of
medical cannabis and cannabis derivatives in Canada under the Access to Cannabis for Medical Purposes
Regulations (ACMPR). Emblem’s state-of-the-art indoor cannabinoid factory and research and development facility is
located in Paris, Ontario. Led by an experienced management team of healthcare executives, accomplished marketing professionals,
and cannabis experts, Emblem is focused on driving shareholder value through product innovation, brand relevance, and access to
patient and consumer channels. Emblem is also the parent company of GrowWise Health Limited, one of Canada’s leading cannabis
education services. Emblem trades under the ticker symbol EMC on the TSX Venture Exchange.
Forward-Looking Statements
This news release contains certain forward-looking statements and forward-looking information (collectively
referred to herein as "forward-looking statements") within the meaning of applicable Canadian securities laws. All statements other
than statements of present or historical fact are forward-looking statements. Forward-looking statements are often, but not always,
identified by the use of words such as "anticipate", "achieve", "could", "believe", "plan", "intend", "objective", "continuous",
"ongoing", "estimate", "outlook", "expect", "may", "will", "project", "should" or similar words, including negatives thereof,
suggesting future outcomes. Management of the Company believes the expectations reflected in such forward-looking statements are
reasonable as of the date hereof but no assurance can be given that these expectations will prove to be correct and such
forward-looking statements should not be unduly relied upon. Various material factors and assumptions are typically applied in
drawing conclusions or making the forecasts or projections set out in forward-looking statements. Those material factors and
assumptions are based on information currently available to the Company, including data from publicly available governmental
sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which
Emblem believes to be reasonable. However, although generally indicative of relative market positions, market shares and
performance characteristics, such data is inherently imprecise. While Emblem is not aware of any misstatement regarding any
industry or government data presented herein, the medical and adult-use marijuana industry involves risks and uncertainties and is
subject to change based on various factors.
Forward-looking statements are not a guarantee of future performance and are subject to and involve a number of
known and unknown risks and uncertainties, many of which are beyond the control of the Company, which may cause the Company's
actual performance and results to differ materially from any projections of future performance or results expressed or implied by
such forward-looking statements. These risks and uncertainties include, but are not limited to, the risks identified in the
Company's December 31, 2017 Management's Discussion and Analysis, which has been filed with the Canadian Securities Administrators
and available on www.sedar.com. Any forward-looking statements are made as of the date hereof and, except as required by law, the
Company assumes no obligation to publicly update or revise such statements to reflect new information, subsequent or otherwise.
Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies
of the Exchange) accepts responsibility for the adequacy or accuracy of this news release.
